KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Vertex Pharmaceuticals (VRTX) over the last 15 years, with Q3 2025 value amounting to -$235.9 million.

  • Vertex Pharmaceuticals' Deferred Taxes fell 9132.2% to -$235.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$489.7 million, marking a year-over-year increase of 784.72%. This contributed to the annual value of -$348.8 million for FY2024, which is 3498.6% up from last year.
  • According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Deferred Taxes is -$235.9 million, which was down 9132.2% from -$113.8 million recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Deferred Taxes peaked at $148.1 million during Q4 2022, and registered a low of -$237.9 million during Q2 2021.
  • Over the past 5 years, Vertex Pharmaceuticals' median Deferred Taxes value was -$118.8 million (recorded in 2024), while the average stood at -$97.7 million.
  • In the last 5 years, Vertex Pharmaceuticals' Deferred Taxes soared by 45346.06% in 2022 and then plummeted by 82195.12% in 2023.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Deferred Taxes stood at -$41.9 million in 2021, then surged by 453.46% to $148.1 million in 2022, then plummeted by 188.45% to -$131.0 million in 2023, then surged by 139.39% to $51.6 million in 2024, then plummeted by 557.17% to -$235.9 million in 2025.
  • Its Deferred Taxes stands at -$235.9 million for Q3 2025, versus -$113.8 million for Q2 2025 and -$191.6 million for Q1 2025.